Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $238.00 | Total: $1,190.00 |
| 1 | 10 | $201.60 | Total: $2,016.00 |
| 1 | 25 | $170.80 | Total: $4,270.00 |
| 1 | 50 | $145.60 | Total: $7,280.00 |
| 1 | 100 | $126.00 | Total: $12,600.01 |
Overview
BMT-124110 is a selective AAK1 inhibitor (IC50: 0.9 nM) with antinociceptive activity. BMT-090605 inhibited BMP-2 induced protein kinase BIKE with IC50 of 17 nM. BMT-090605 inhibits cyclin G-associated kinase GAK with an IC50 of 99 nM.
Chemical Properties
| Molecular Formula | C21H27N3O3 |
| Molecular Weight | 369.46 |
| CAS Numbers | 1679371-59-5 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | N(C(C)=O)C=1C=C2C=3C(=CC(OC[C@@](CC(C)C)(C)N)=CC3)OCC2=CN1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Walter Kostich, et al. Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain. J Pharmacol Exp Ther. 2016 Sep;358[3] 371-86.